These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3484802)

  • 1. Lack of depletion of striatal dopamine by phenylpiperidine analgesics.
    Baldessarini RJ; Neumeyer JL
    N Engl J Med; 1986 Mar; 314(10):649. PubMed ID: 3484802
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA; Jarvis MF; Wagner GC
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):145-8. PubMed ID: 3875884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Finnegan KT; Irwin I; Delanney LE; Ricaurte GA; Langston JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1144-51. PubMed ID: 3498815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases acetylcholine and decreases dopamine in mouse striatum: both responses are blocked by anticholinergic drugs.
    Hadjiconstantinou M; Cavalla D; Anthoupoulou E; Laird HE; Neff NH
    J Neurochem; 1985 Dec; 45(6):1957-9. PubMed ID: 3877147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Donnan GA; Willis GL; Kaczmarczyk SJ; Rowe P
    J Neurol Sci; 1987 Feb; 77(2-3):185-91. PubMed ID: 3493329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K; Ogawa N; Sora YH
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological manipulations with MPTP.
    Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
    J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA
    Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants fail to inhibit depletion of striatal dopamine by MPTP.
    Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP
    Neurology; 1986 May; 36(5):735. PubMed ID: 3486381
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.
    Eldridge R; Rocca WA
    N Engl J Med; 1985 Oct; 313(18):1159-60. PubMed ID: 3876508
    [No Abstract]   [Full Text] [Related]  

  • 14. Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice.
    Navneet AK; Appukuttan TA; Pandey M; Mohanakumar KP
    Amino Acids; 2008 Aug; 35(2):457-61. PubMed ID: 17701098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.
    Jacobowitz DM; Burns RS; Chiueh CC; Kopin IJ
    Psychopharmacol Bull; 1984; 20(3):416-22. PubMed ID: 6332329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
    Pileblad E; Nissbrandt H; Carlsson A
    J Neural Transm; 1984; 60(3-4):199-203. PubMed ID: 6084705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL; Hashim A; Lajtha A; Sershen H
    J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biochemical effects of 4-phenylpyridine, 2-phenylpyridine, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rodents.
    Hassan MN; Thakar JH; Grimes JD
    Adv Neurol; 1990; 53():219-23. PubMed ID: 2239461
    [No Abstract]   [Full Text] [Related]  

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.